Chengfeng Yang

6PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 15, 2026
AB-Free Kava and Dihydromethysticin Inhibit Chronic Hexavalent Chromium Exposure-Induced Cell Malignant Transformation through Down-Regulating RNA Splicing Factor SNRPA1 Expression.

|Dec 11, 2024
Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities.

Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang

|Apr 05, 2021
The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis.

Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang

|Apr 23, 2019
Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis.

Zhishan Wang, Yunfei Li, Yajuan Xiao

|Aug 08, 2014
MicroRNAs: novel players in cancer diagnosis and therapies.

Aaron L Oom, Brock A Humphries, Chengfeng Yang

Pageof 1

Frequent Collaborators

1 joint publications

Aaron L Oom

1 joint publications

Fumitaka Takeshita

1 joint publications

Mohammad Burhan Uddin

1 joint publications

Chengguo Xing